News

As tariffs, HHS workforce cuts and the ouster of CBER Director Peter Marks threaten the “lifeblood” of the cell and gene ...
The suspension of the vital program that is designed to “ensure consistency and accuracy” across around 170 labs that test ...
As Marty Makary nears the end of his first month on the job, the FDA Commissioner sat down for two interviews, offering ...
The FDA has discussed with vaccine-maker Novavax the need for an additional trial of its COVID-19 vaccine as a post-approval ...
Following massive layoffs and cuts at the FDA, Makary’s plan for the agency is yet to fully unfold. But he has hinted at what ...
But with FDA action, it would be the third vaccine ... days after former director Dr. Peter Marks was forced out. In his resignation letter, Marks cited "efforts being advanced by some on the ...